Skip to content

NAGE NAGE Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

eXoZymes Inc. Common Stock logo
eXoZymes Inc. Common StockEXOZ
Lifevantage Corporation logo
Lifevantage CorporationLFVN
Biote Corp. logo
Biote Corp.BTMD
BellRing Brands logo
BellRing BrandsBRBR
CVR Partners logo
CVR PartnersUAN
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP

Other financials

Income statement

See full
Revenue$31.5M+3.3%
Gross profit$20.0M+3.3%
Operating income$1.6M-67.0%
Net income$6.3M+24.8%
EPS (diluted)$0.07+16.7%

Balance sheet

See full
Cash & equivalents$66.5M+19.7%
Total debt$2.6M-26.9%
Total equity$82.3M+48.8%
Total assets$114.3M+40.6%

Cash flow

See full
Operating cash flow-$1.2M-115%

Valuation

See full
Market cap$254.07M-74.9%
Enterprise value$190.09M-79.7%
P/E13.6×-43.5×
P/S-6.8×

Profitability

See full
Gross margin64.3%+1.8pp
Operating margin10%-2.2pp
Net margin14.3%+1.2pp
FCF margin-70.4%

Returns & leverage

See full
Return on equity27.1%-6.4pp
Debt / equity0.0×
Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NAGE's interest income (expense), nonoperating?
NAGE (NAGE) reported interest income (expense), nonoperating of $375K in Q1 2026.
How has NAGE's interest income (expense), nonoperating changed year-over-year?
NAGE's interest income (expense), nonoperating decreased by 18.3% year-over-year, from $459K to $375K.
What is the long-term trend for NAGE's interest income (expense), nonoperating?
Over 2 years (2023 to 2025), NAGE's interest income (expense), nonoperating has grown at a 70.1% compound annual growth rate (CAGR), from $661K to $1.91M.